healthy senior subjects
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: general elderly people
Exclusion criteria
Exclusion criteria: The patients with Parkinson's disease The patients treated for thing antipsychotics treated for an antiparkinson agent There are a serious heart, lung, liver, renal dysfunction More than systolic blood pressure 180mmHg More than BMI 30 More than HbA1c 8.0 It is less than 8.0 mg/dl of hemoglobin, Less than 20000 platelet /mm3 AST, ALT, LDH, ALP, gGTP, BUN, a Cre level are less than eGFR 30ml/min more than 3 times of the normal upper limit level The AV block where is atrial fibrillation, 2 degrees or more with an electrocardiogram, the patients with a history of treatment of the malignant tumor within thing with the malignant tumor, the past five years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacokinetics parameter of blood levodopa levels | — |
Secondary
| Measure | Time frame |
|---|---|
| Hypotensive effect, fatigue improved work, the Clinical Global Impressions (CGI) -ImprovementScale | — |
Countries
Japan
Contacts
Ehime University Graduate School of medicine Neurology and Clinical pharmacology